Analysten nachrichten

Aegis Capital Corp. Acted as Sole Bookrunner on an $8 Million Underwritten Public Offering for BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV)

External page is loading, the page should display in a few seconds..

    Follow @AnalystenNews on Twitter!